What's new

2024 Annual Report on EudraVigilance for the European P...

Mar 20, 2025 0

2024 Annual Report on EudraVigilance for the European Parliament, the Council an...

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025 0

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide,...

PSUSA/00000329/202407

PSUSA/00000329/202407

Mar 20, 2025 0

PSUSA/00000329/202407

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 93, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025 0

Human medicines European public assessment report (EPAR): Humira, adalimumab, Da...

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Date of authorisation: 09/12/2009, Revision: 48, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025 0

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococ...

Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025 0

Human medicines European public assessment report (EPAR): Constella, linaclotide...

Human medicines European public assessment report (EPAR): Scintimun, besilesomab, Date of authorisation: 11/01/2010, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025 0

Human medicines European public assessment report (EPAR): Scintimun, besilesomab...

Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025 0

Human medicines European public assessment report (EPAR): Sivextro, tedizolid ph...

Minutes of the HMPC meeting 20-22 January 2025

Mar 20, 2025 0

Minutes of the HMPC meeting 20-22 January 2025

Opinions and letters of support on the qualification of novel methodologies for medicine development

Opinions and letters of support on the qualification of...

Mar 20, 2025 0

Opinions and letters of support on the qualification of novel methodologies for ...

Emblaveo

Mar 20, 2025 0

Emblaveo

Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025 0

Human medicines European public assessment report (EPAR): Idefirix, imlifidase, ...

Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025 0

Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, D...

Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Date of authorisation: 18/12/2018, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Namuscla, mexiletine h...

PSUSA/00010511/202407

PSUSA/00010511/202407

Mar 19, 2025 0

PSUSA/00010511/202407

Human medicines European public assessment report (EPAR): Tenofovir disoproxil Zentiva, tenofovir disoproxil, Date of authorisation: 15/09/2016, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Tenofovir disoproxil Z...

Human medicines European public assessment report (EPAR): Jayempi, azathioprine, Date of authorisation: 21/06/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Jayempi, azathioprine,...

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pom...

Human medicines European public assessment report (EPAR): Leflunomide ratiopharm, leflunomide, Date of authorisation: 28/11/2010, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Leflunomide ratiopharm...

Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Pandemic influenza vac...

Human medicines European public assessment report (EPAR): Tolura, telmisartan, Date of authorisation: 04/06/2010, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Tolura, telmisartan, D...

Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Rivastigmine Actavis, ...

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir disoproxil, Date of authorisation: 09/11/2016, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovi...

Human medicines European public assessment report (EPAR): Rasagiline ratiopharm, rasagiline, Date of authorisation: 12/01/2015, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025 0

Human medicines European public assessment report (EPAR): Rasagiline ratiopharm,...

20
21
22
23
24

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.